Medication adherence and hospitalizations in older patients with coronary heart disease in Vietnam

IF 3 3区 医学 Q2 PHARMACOLOGY & PHARMACY British journal of clinical pharmacology Pub Date : 2025-02-05 DOI:10.1111/bcp.16405
Tan Van Nguyen, Hang Thi Thuy Nguyen, Dung Ngoc Truong, Viet Quoc Nguyen, Huy Quang Nguyen, Huy Quoc Nguyen, Trinh Thi Kim Ngo, Erkihun Amsalu, Wei Jin Wong, Tu Ngoc Nguyen
{"title":"Medication adherence and hospitalizations in older patients with coronary heart disease in Vietnam","authors":"Tan Van Nguyen,&nbsp;Hang Thi Thuy Nguyen,&nbsp;Dung Ngoc Truong,&nbsp;Viet Quoc Nguyen,&nbsp;Huy Quang Nguyen,&nbsp;Huy Quoc Nguyen,&nbsp;Trinh Thi Kim Ngo,&nbsp;Erkihun Amsalu,&nbsp;Wei Jin Wong,&nbsp;Tu Ngoc Nguyen","doi":"10.1111/bcp.16405","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>This study aimed to assess medication adherence among older people with coronary heart disease and its relationship with hospitalizations.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This is a prospective cohort study conducted at the outpatient clinics of a major hospital in Vietnam from November 2022 to June 2023. Consecutive older patients with coronary heart disease were recruited and followed for 6 months. Medication adherence was defined using the five-item Medication Adherence Report Scale (MARS-5). Multivariable logistic regression models were applied to examine the impact of medication adherence on hospitalization due to cardiovascular disease (CVD) and all-cause hospitalization.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>There were 643 participants, mean age 73 ± 8 years, 74.3% were male. Overall, 76.4% (491/643) were classified as ‘adherent’. Over 6 months follow-up, 23.3% of the participants were admitted to hospital and of these hospitalizations, 9.2% were due to CVD. The CVD-related hospitalization rate was significantly higher in the non-adherent group compared to the adherent group (13.8% <i>vs</i>. 7.7%, <i>P</i> = 0.023, respectively). In logistic regression models, medication adherence was associated with significantly reduced odds of CVD-related hospitalization (adjusted odds ratio [OR] 0.48, 95% confidence interval [CI] 0.27–0.86). Medication adherence was also associated with a trend of reduced all-cause hospitalization (adjusted OR 0.75, 95% CI 0.49–1.15).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This study showed a positive relationship between medication adherence and reduced risk of CVD-related hospitalization in older people with coronary heart disease. Healthcare providers should consider incorporating adherence assessment into the long-term care for older patients with coronary heart disease.</p>\n </section>\n </div>","PeriodicalId":9251,"journal":{"name":"British journal of clinical pharmacology","volume":"91 6","pages":"1771-1779"},"PeriodicalIF":3.0000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcp.16405","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of clinical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16405","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

This study aimed to assess medication adherence among older people with coronary heart disease and its relationship with hospitalizations.

Methods

This is a prospective cohort study conducted at the outpatient clinics of a major hospital in Vietnam from November 2022 to June 2023. Consecutive older patients with coronary heart disease were recruited and followed for 6 months. Medication adherence was defined using the five-item Medication Adherence Report Scale (MARS-5). Multivariable logistic regression models were applied to examine the impact of medication adherence on hospitalization due to cardiovascular disease (CVD) and all-cause hospitalization.

Results

There were 643 participants, mean age 73 ± 8 years, 74.3% were male. Overall, 76.4% (491/643) were classified as ‘adherent’. Over 6 months follow-up, 23.3% of the participants were admitted to hospital and of these hospitalizations, 9.2% were due to CVD. The CVD-related hospitalization rate was significantly higher in the non-adherent group compared to the adherent group (13.8% vs. 7.7%, P = 0.023, respectively). In logistic regression models, medication adherence was associated with significantly reduced odds of CVD-related hospitalization (adjusted odds ratio [OR] 0.48, 95% confidence interval [CI] 0.27–0.86). Medication adherence was also associated with a trend of reduced all-cause hospitalization (adjusted OR 0.75, 95% CI 0.49–1.15).

Conclusions

This study showed a positive relationship between medication adherence and reduced risk of CVD-related hospitalization in older people with coronary heart disease. Healthcare providers should consider incorporating adherence assessment into the long-term care for older patients with coronary heart disease.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
越南老年冠心病患者的用药依从性和住院情况。
目的:本研究旨在评估老年冠心病患者的药物依从性及其与住院治疗的关系。方法:这是一项前瞻性队列研究,于2022年11月至2023年6月在越南一家大医院的门诊进行。连续招募老年冠心病患者,随访6个月。用药依从性采用5项用药依从性报告量表(MARS-5)进行定义。采用多变量logistic回归模型检验药物依从性对心血管疾病(CVD)住院和全因住院的影响。结果:参与者643人,平均年龄73±8岁,男性74.3%。总体而言,76.4%(491/643)被归类为“粘附”。在6个月的随访中,23.3%的参与者住院,其中9.2%是由于心血管疾病。非依从组cvd相关住院率明显高于依从组(13.8% vs. 7.7%, P = 0.023)。在logistic回归模型中,药物依从性与cvd相关住院的几率显著降低相关(校正优势比[OR] 0.48, 95%可信区间[CI] 0.27-0.86)。药物依从性也与全因住院减少的趋势相关(调整OR 0.75, 95% CI 0.49-1.15)。结论:本研究显示,老年冠心病患者服药依从性与心血管疾病相关住院风险降低呈正相关。医疗保健提供者应考虑将依从性评估纳入老年冠心病患者的长期护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.30
自引率
8.80%
发文量
419
审稿时长
1 months
期刊介绍: Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.
期刊最新文献
Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta-analysis. The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach. Unintentional medication discrepancies and postoperative adverse drug events in patients with cancer: A prospective cohort study. Medical versus science students: Knowledge, perceptions and learning of core pharmacology concepts. Placebo response and its influencing factors in acne vulgaris: A model-based meta-analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1